the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences

Market Research Report

Genetic Engineering

Published by Global Industry Analysts, Inc. Contact us : +1-860-674-8796
Published 2009/10 Content info Pages: 63
Product code GO101186
Price From  US $ 950 Order/Price list
US $ 950 PDF by E-mail (Single User License)
US $ 2850 PDF By E-mail (Global License to Company and its Fully-owned Subsidiaries)

Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

1. INDUSTRY OVERVIEW

  • Genetic Engineering: A Prelude
  • The Evolution and Progress of GM Crops
  • GM Crops Gain Global Acceptance
  • GM Cultivation Gains Prominence in Developing Nations
  • Rising Prices, Food Shortage Make Biotech Grains Attractive
  • Challenges to GM Crops Adoption
  • Biotech Regulatory Measures Hinder Crop Domestication
  • Governments Not to Give Up on GM Hope
  • US - The Largest Producer of GM Crops
  • Major Market Participants

2. MARKET DYNAMICS

  • Global Food Demand to Drive Need for GM Crops
  • Genetic Engineering - A Solution for Food Crisis!
  • Harmful or Healthy: Breaking The Myth About GM Crops
  • Non-food Sectors to Benefit from GE Technology
  • Genetic Engineering and Enzymes
  • GE to Help Starch and Sugar Processing Enzyme Market
  • GE to Drive Demand for Bakery Enzymes

3. ISSUES AND CONCERNS

  • The GM Food Issue Continues
  • Nations at Crossroads to Accept or Object GE Crops
  • Nations Set Global Agenda to Settle GM Crop Controversies

4. REGIONAL TRENDS

  • US Soybean and Corn Crop to Witness Robust Growth
  • GMO Crops' Future Hinges on Co-Existence Measures in EU
  • UK Government' s GM Crops Proposal Faces Rebuff
  • Spanish Transgenic Corn Plantation Increases
  • Chinese Biopharmaceutical Market to Continue its Growth Spurt
  • Government to Support Biopharmaceutical Innovation
  • India - The Leading Cultivator of Bt Cotton
  • India Ousts China in Bt Cotton Cultivation
  • GM Crops to Earn Good Returns for Australia
  • Biotechnology - A Boon for Agriculture in Malaysia
  • Biotech Crops Cultivation Zooms in South Africa

5. GENETIC ENGINEERING: AN OVERVIEW

  • The Concept...
  • Molecular Basics - The Gene
  • Genome - The Information Pool
  • Evolution of Genetic Engineering
  • Historical Developments in Genetic Engineering:
  • The Human Genome Project
  • Significant Events in the Past
  • Gene Therapy
  • Types of Gene Therapy
  • Monogenic Gene Therapy
  • Suicide Gene Therapy
  • Antisense Gene Therapy
  • Human Genetic Engineering
  • Genetic Engineering in Animals
  • Role of Biotechnology in Agriculture
  • Insect Resistant Crops Vs. Herbicide Tolerant Crops
  • Genetically Modified Foods
  • GM Food Faces Worldwide Criticism During Initial Years
  • Benefits of Genetically Modified Foods
  • Pest Resistance
  • Cold Tolerance
  • Herbicide Tolerance
  • Drought and Salinity Tolerance
  • Disease Resistance
  • Phytoremediation
  • Nutrition
  • Pharmaceuticals
  • Negative Impacts of GM Foods
  • Possibility of Crosspollination
  • Decreased Pesticides Effectiveness
  • Unintentional Destruction of Other Species
  • Health Concerns Related to GM Foods
  • Cost Concerns Related to GM Foods
  • Genetic Engineering and Food Processing
  • Genetic Engineering and Regulatory Environment
  • Patents - An Overview

6. GENE THERAPY - A REVIEW

  • Factors Influencing Gene Therapy' s Future Development
  • Human Genome Analysis
  • Gene Therapy - The Next Generation Cardiovascular Therapy
  • Public Support for Gene Therapy
  • RNAi Bode Bright Prospects
  • Factors Hampering Gene Therapy FutureDevelopment
  • Stringent US and European Regulatory Laws Prolongs Gene Therapy Development
  • Identifying Genetic Fault
  • Immune Response
  • Delivering Genetic Materials into Patient Cells
  • Multigene Disorders
  • Side Effects
  • Push Towards Germline Gene Transfer
  • Technical Limitations
  • Commercialization: A Road Uphill
  • Time Line in Gene Therapy Drug Development
    • Table 1: Gene Therapy Clinical Trials (2007): Percentage Breakdown by Geographic Region for the US, Europe, Canada, Japan and Rest of World
    • Table 2: Gene Therapy Clinical Trials Worldwide (2007): A Split by Development Phase
  • Various Gene Therapy Products Under Development (2007)
  • Target Diseases and Players Involved
  • Key Players by Application Area
    • Table 3: Gene Therapy Clinical Trials Worldwide (2007): Percentage Breakdown by Disease/ Application Area for Cancer, Heart Disease, Monogenic Diseases, Infectious Diseases and Others
    • Table 4: Gene Therapy Clinical Trials Worldwide (2007):Percentage Breakdown by Gene Type Transferred for Antigen, Cytokine, Tumor Suppressor, Growth Factor, Suicide, Deficiency and Others
    • Table 5: Gene Therapy Clinical Trials Worldwide (2007): Percentage Breakdown by Vector Type for Adenovirus, Retrovirus, Naked/Plasmid DNA, Lipofection, Vaccinia Virus, Poxvirus, Adeno- associated Virus, and Others
  • Gene Therapy Industry in Europe and the US - A Comparison

7. RESEARCH AND DEVELOPMENT

  • Anti-Clotting Drug from GE Goats to Win Approval
  • British Midlands University to Reveal Genetic Code of Bacterium Causing
  • Hospital Acquired Infection
  • Genetically Engineered BMPs to Facilitate Bone Formation in Orthopedic Surgeries
  • GE Finds Application in Obesity Control
  • Trubion Develops Advanced mAbs
  • New Study Reveals microRNA' s Role in Heart Failure
  • Cell-based Assays to Aid in Early Drug Discovery
  • Inhibition of SHIP Gene to Minimize Risk in Stem Cell Transplants
  • Drug Discovery to Employ Chemical Genetics
  • GE to Aid in the Discovery of New Enzyme Sources
  • Demand for Lactose-Free Products Boosts Enzymes Applications Market

8. MERGERS & ACQUISITIONS

  • RJH Industries Acquires Philippines Royal Oil
  • Monsanto Takes Over Aly Participacoes
  • Monsanto Acquires De Ruiter Seeds Group
  • Lydall Announces Acquisition of DSM Solutech
  • Biotie Completes Acquisition of elbion
  • Pfizer Animal Health Acquires Catapult Genetics
  • Monsanto Completes Marmot Acquisition
  • BioEnergy Takes Over Assets of OmniGene Bioproducts
  • BRAIN Takes Over Industrial Biotech Assets of MerLion Pharmaceuticals
  • MTS Health Investors Acquires DNA Diagnostic Center
  • Bayer HealthCare Takes Over Direvo Biotech
  • QIAGEN Completes Acquisition of Corbett Life Science
  • ChemVentures to Acquire BioFocus DPI Chemistry Facility
  • Nanobac Pharmaceuticals to Take Over DNAPrint Genomics
  • GlaxoSmithKline to Take Over Genelabs Technologies
  • Invitrogen Merges with Applied Biosystems
  • NitroMed Enters into Definitive Merger Agreement with Archemix
  • Monsanto Completes Acquisition of Delta & Pine Land
  • Inverness Medical Innovations Acquires Biosite
  • Avesta Biotherapeutics Takes Over Siegfried Biologics
  • Entelos Takes Over Iconix Biosciences
  • Illumina Takes Over Solexa
  • Celera Group Acquires Atria Genetics
  • CytoDyn Acquires Advanced Genetic Technologies
  • Takeda Europe to Take Over Paradigm Therapeutics
  • AmerisourceBergen Announces Acquisition of IgG of America
  • GlaxoSmithKline Plans Praecis Acquisition

9. RECENT INDUSTRY ACTIVITY

  • Eureka, Glycos Partner to Develop Bacterium for Biorefinery
  • Genzyme Acquires Rights to MabCampath, Fludara and Leukine
  • Quantel Announces Genetic Engineering Technology Support for Lasergraphics
  • USDA to Deregulate Syngenta' s GE Corn
  • Archer Daniels, Deere & Company and Monsanto to Form Partnership
  • Genzyme Collaborates with ICGEB
  • Veredus Partners with STMicroelectronics to Establish Bio-Application Lab
  • Invitrogen Gains License for Stem Cell Line
  • Millipore Enters into Agreement with Solabia
  • Advanced Cell Forms Joint Venture with CHA Biotech
  • Luminex Enters into Agreement with Mingyuan
  • ProGenTech Inks Agreement with Human Genetic Signatures
  • Monsanto and China National Seed Group Sign Agreement
  • Monsanto and Syngenta Sign Royalty-Bearing Licensing Agreement
  • Affymetrix Signs Definitive Agreement with Panomics
  • Sanofi-Aventis to Use Regeneron' s Genetic Modification Method
  • Monsanto to Build DEKALB Corn Seed Production Facility
  • Qatar Receives Grant to Augment Agro-Genetic Engineering Capacity
  • Monsanto Expands Jerseyville Facility
  • Sirtris Pharmaceuticals Obtains Approval for NamPRT
  • Origin Agritech Obtains License for Phytase Corn
  • Shenyang Xiehe Establishes Genetic Engineering Subsidiary
  • BioServe Enters into Alliance with DNAPrint Genomics
  • Evogene Teams Up with Ormat on Biodiesel
  • EMD and Dendritic Nanotechnologies Enter into License and Supply Agreement
  • AureoGen Biosciences Enters into Agreement with Takara Bio
  • Shanghai Wanxing Inks Agreement with Blue Blood Biotech
  • Stem Cell Sciences Signs Agreement with RIKEN Centre
  • Olympus and National Center for Biological Sciences Open New Facility
  • Biocentury Obtains Approval for Hybrid Cotton Seed in India
  • Novozymes to Expand Operation Base
  • Cell Therapeutics to Develop More Targeted Treatments for Cancer

10. PRODUCT/SERVICE LAUNCHES

  • Affymetrix Introduces MyGeneChip Program
  • Genomnz to Unveil DNA Testing Service
  • Whatman Introduces EasiCollect
  • Nanoxis Launches Membrane Protein
  • Few Important Terms Used in Genetic Engineering
  • Chromosomes
  • Genome
  • Recombinant DNA
  • Retroviruses
  • Plasmids
  • Transgenic Animals and Plants
  • Gene Therapy

GLOBAL DIRECTORY

Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.